Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: A model for preclinical studies

EuroIntervention

Volumn 6, Issue 2, 2010, Pages 261-268

  Thim, Troels ^a   Hagensen, Mette Kallestrup ^a   Drouet, Ludovic ^b   Sollier, Claire Bal Dit ^b   Bonneau, Michel ^c   Granada, Juan F ^d   Nielsen, Lars Bo ^e   Paaske, William P ^a   Bøtker, Hans Erik ^a   Falk, Erling ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Institut des Vaisseaux et du Sang   (France)

^c CEMAGREF   (France)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Coronary atherosclerosis; Hypercholesterolaemia; Imaging; Percutaneous coronary intervention; Vulnerable plaque

Indexed keywords

CHOLESTEROL; GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; BALLOON; BLEEDING DISORDER; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS BREEDING; EXPERIMENTAL MODEL; FAMILIAL HYPERCHOLESTEROLEMIA; FEEDING; LIPID BLOOD LEVEL; MALE; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; SWINE; ANIMAL; BODY SIZE; CORONARY ARTERY DISEASE; DISEASE MODEL; HYPERLIPOPROTEINEMIA TYPE 2;

ANIMALS; BODY SIZE; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; HYPERLIPOPROTEINEMIA TYPE II; MALE; SWINE;

EID: 77957589333     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I2A42     Document Type: Article

References (24)

1. Rapacz J, Hasler-Rapacz J, Taylor KM, Checovich WJ, Attie AD. Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Science. 1986;234:1573-1577. (Pubitemid 17118721)
2. Prescott MF, McBride CH, Hasler-Rapacz J, Von LJ, Rapacz J. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol. 1991;139:139-147.
3. Prescott MF, Hasler-Rapacz J, von Linden-Reed J, Rapacz J. Familial hypercholesterolemia associated with coronary atherosclerosis in swine bearing different alleles for apolipoprotein B. Ann N Y Acad Sci. 1995;748:283-292.
4. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500-1510. (Pubitemid 46986103)
5. Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, Chronos NAF, Robinson KA, Waksman R, Weinberger J, Wilson GJ, Wilensky RL. Drug-Eluting Stents in Preclinical Studies: Updated Consensus Recommendations for Preclinical Evaluation. Circ Cardiovasc Intervent. 2008;1:143-153.
6. Schwartz RS, Edelman ER, Carter A, Chronos NA, Rogers C, Robinson KA, Waksman R, Machan L, Weinberger J, Wilensky RL, Goode JL, Hottenstein OD, Zuckerman BD, Virmani R. Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation. 2004;110:2498-2505. (Pubitemid 39407359)
7. Granada JF, Kaluza GL, Wilensky RL, Biedermann BC, Schwartz RS, Falk E. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention.. 2009;5:140-148.
8. Hasler-Rapacz J, Ellegren H, Fridolfsson AK, Kirkpatrick B, Kirk S, Andersson L, Rapacz J. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet. 1998;76:379-386. (Pubitemid 28163058)
9. Nielsen LB, Stender S, Jauhiainen M, Nordestgaard BG. Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. J Clin Invest. 1996;98:563-571. (Pubitemid 26255758)
10. Christoffersen C, Jauhiainen M, Moser M, Porse B, Ehnholm C, Boesl M, Dahlback B, Nielsen LB. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J Biol Chem. 2008;283:1839-1847.
11. Maeng M, Olesen PG, Emmertsen NC, Thorwest M, Nielsen TT, Kristensen BO, Falk E, Andersen HR. Time course of vascular remodeling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model. Coron Artery Dis. 2001;12:285-293. (Pubitemid 32549747)
12. Falk E, Fallon JT, Mailhac A, Fernandez-Ortiz A, Meyer BJ, Weng D, Shah PK, Badimon JJ, Fuster V. Muramidase: A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease. Cardiovascular Pathology. 1994;3:183-189. (Pubitemid 24266252)
13. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
14. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316-2325. (Pubitemid 37509739)
15. Kolodgie FD, Burke AP, Nakazawa G, Virmani R. Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol. 2007;27:986-989.
16. Reitman JS, Mahley RW, Fry DL. Yucatan miniature swine as a model for diet-induced atherosclerosis. Atherosclerosis. 1982;43:119-132. (Pubitemid 12158743)
17. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes. 2001;50:1654-1665. (Pubitemid 33639607)
18. Mohler ER, III, Sarov-Blat L, Shi Y, Hamamdzic D, Zalewski A, Macphee C, Llano R, Pelchovitz D, Mainigi SK, Osman H, Hallman T, Steplewski K, Gertz Z, Lu MM, Wilensky RL. Site-specific atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature. Arterioscler Thromb Vasc Biol. 2008;28:850-855. (Pubitemid 351544098)
19. Wilensky RL, Shi Y, Mohler ER, III, Hamamdzic D, Burgert ME, Li J, Postle A, Fenning RS, Bollinger JG, Hoffman BE, Pelchovitz DJ, Yang J, Mirabile RC, Webb CL, Zhang L, Zhang P, Gelb MH, Walker MC, Zalewski A, Macphee CH. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med. 2008;14:1059-1066.
20. Chatzizisis YS, Jonas M, Coskun AU, Beigel R, Stone BV, Maynard C, Gerrity RG, Daley W, Rogers C, Edelman ER, Feldman CL, Stone PH. Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: an intravascular ultrasound and histopathology natural history study. Circulation. 2008;117:993-1002.
21. Chatzizisis YS, Jonas M, Beigel R, Coskun AU, Baker AB, Stone BV, Maynard C, Gerrity RG, Daley W, Edelman ER, Feldman CL, Stone PH. Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques. Atherosclerosis. 2009;203:387-394.
22. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275. (Pubitemid 30262927)
23. Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol. 2007;27:705-713. (Pubitemid 46606695)
24. Thim T, Hagensen MK, Bentzon JF, Falk E. From vulnerable plaque to atherothrombosis. J Intern Med. 2008;263:506-516. (Pubitemid 351545740)